{
    "clinical_study": {
        "@rank": "105994", 
        "arm_group": [
            {
                "arm_group_label": "nitrate supplementation", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive 7-day nitrate supplementation at the end of the radiotherapy."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients will receive 7-day placebo supplementation at the end of the radiotherapy"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate whether dietary nitrate supplementation could\n      improve the plasma nitrate levels for nasopharyngeal carcinoma patients receiving concurrent\n      chemo-radiation therapy."
        }, 
        "brief_title": "Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Nasopharyngeal Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Nasopharyngeal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Twenty patients diagnosed as nasopharyngeal carcinoma will be recruited. A 70 ml beetroot\n      juice containing 0.45g nitrate or placebo will be provided to the patients for 7 days at the\n      end of the radiotherapy . The plasma nitrate levels will be determined before radiotherapy,\n      before intervention and after intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with newly diagnosed stages III-IVb (UICC 2002) nasopharyngeal carcinomas,\n             will be recruited.\n\n        Exclusion Criteria:\n\n          -  Patients with local invasion or metastatic foci in salivary glands, detected by MRI\n             and PET-CT prior to treatment, were excluded, as were patients suffering from\n             diseases, such as Sjogren's syndrome, or with a history of surgery to major salivary\n             glands, or prior head and neck radiotherapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02044562", 
            "org_study_id": "13-07-08"
        }, 
        "intervention": [
            {
                "arm_group_label": "nitrate supplementation", 
                "description": "A 70 ml beetroot juice containing 0.45g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.", 
                "intervention_name": "nitrate supplementation", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "A 70 ml placebo containing 0 g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "dietary nitrate", 
            "radiotherapy", 
            "nasopharyngeal carcinoma"
        ], 
        "lastchanged_date": "January 22, 2014", 
        "location": {
            "contact": {
                "email": "xingminqu@sina.com", 
                "last_name": "Xingmin Qu", 
                "phone": "8610-57099421"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100050"
                }, 
                "name": "Capital Medical University School of Stomatology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemo-radiotherapy", 
        "overall_official": {
            "affiliation": "Professor and Vice President of Capital Medical University", 
            "last_name": "Songlin Wang, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The plasma nitrate level will be determined one day after nitrate supplementation.", 
            "measure": "plasma nitrate level", 
            "safety_issue": "Yes", 
            "time_frame": "one day after nitrate supplementation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02044562"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Capital Medical University", 
            "investigator_full_name": "Songlin Wang", 
            "investigator_title": "Professor and Vice President", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The quality of life will be assessed one day after nitrate supplementation.", 
            "measure": "quality of life", 
            "safety_issue": "Yes", 
            "time_frame": "one day after nitrate supplementation"
        }, 
        "source": "Capital Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Capital Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}